Prognosys/Febit partnership produces genome-to-array service

December 18, 2007 — A partnership between Prognosys Biosciences Inc. of La Jolla, Calif., and the German biotech company Febit Biomed GmbH is offering a new genome-to-array service.

The service gives scientists access to the latest technology and know-how in sequencing and microarrays even for DNA where no standard microarrays are available, the release said. Using this service, the companies said, scientists can go from biological genetic material to a working microarray experiment in weeks.

Prognosys Biosciences is contributing its sequencing technology to the partnership. Febit’s Geniom Technology is used for preparative sample enrichment and supports the assembly process following sequencing.

The data resulting from the procedure is the basis for synthesis of a biochip for microarray analysis. The biochip can be produced and analyzed in the Geniom One instrument either by the customer or as a service by Febit.

In addition, Febit said it will launch a new microarray analysis device in spring 2008, the Geniom RT Analyzer.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.